Advertisement

Search Results for "pharmeasy"

Forbes List Logo
What went wrong at PharmEasy and can it find a cure?
The online drugs and medical services startup is reportedly raising Rs 2,400 crore in fresh funds at a 90 percent markdown to it previous valuation
ByVarsha Meghani
How PharmEasy disrupted the brick and mortar industry through differentiated offerings
ByBrand Connect
From Byju-Aakash to PharmEasy-Thyrocare: Top 10 startup acquisitions of 2021 in India
BySamidha Jain
Ather launches 450X-Gen3; Shiprocket buys Omuni; PharmEasy in funding talks; IIT-K innovates memory muscle for space robots
ByHarichandan Arakali
From zero debt unicorn to successful exit: Arokiaswamy Velumani's journey with Thyrocare Technologies and life since
ByNeha Bothra
Bitter Dose & Harsh Reality: Why are online pharmacies and healthtech platforms bleeding?
ByRajiv Singh
How India's top unicorns have reinvented themselves
ByBrand Connect

Latest News

Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement